DCF — HOUSTON HEALTHCARE MEDICAL CENTER
Enterprise Value: $-293.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-293.6M
Enterprise Value
$-92.6M
PV of Cash Flows
$-201.0M
PV of Terminal Value
$-323.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $175.3M | $-18.4M | -11.0% | $-25.9M | $-23.5M |
| Year 2 | $180.5M | $-17.2M | -10.0% | $-24.8M | $-20.5M |
| Year 3 | $185.9M | $-15.8M | -9.0% | $-23.7M | $-17.8M |
| Year 4 | $191.5M | $-15.4M | -8.0% | $-23.5M | $-16.0M |
| Year 5 | $197.3M | $-15.3M | -8.0% | $-23.7M | $-14.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-293.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$170.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11023912676738143
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5